Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

28.6%

4 terminated/withdrawn out of 14 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
1(20.0%)
Phase 4
1(20.0%)
5Total
N/A(3)
Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded